Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 932 M911 M873 M893 M961 M 3.64 B Research & development ————— — Operating income 208 M317 M148 M2 M241 M 708 M Non-Operating Income, Total 326 M278 M363 M-162 M-521 M -42 M Interest expense, net of interest capitalized 158 M159 M153 M142 M149 M 603 M Non-Operating Income, excl. Interest Expenses 149 M67 M141 M-314 M-740 M -846 M Unusual income/expense 19 M52 M69 M10 M70 M 201 M Pretax income 353 M279 M147 M476 M384 M 1.29 B Equity in earnings 144 M134 M-41 M411 M89 M 593 M Taxes 61 M62 M37 M22 M81 M 202 M Non-controlling/minority interest -3 M-2 M2 M-2 M5 M 3 M After tax other income/expense 94 M10 M-94 M15 M39 M -30 M Net income before discontinued operations 295 M219 M108 M456 M298 M 1.08 B Discontinued operations ————— — Net income 295 M219 M108 M456 M298 M 1.08 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 295 M219 M108 M456 M298 M 1.08 B Basic earnings per share (Basic EPS) 0.610.450.220.950.62 2.24 Diluted earnings per share (Diluted EPS) 0.610.450.220.950.62 2.24 Average basic shares outstanding 483 M484 M484 M484 M484 M — Diluted shares outstanding 483 M484 M484 M484 M484 M — EBITDA 495 M608 M444 M309 M534 M 1.9 B EBIT 208 M317 M148 M2 M241 M 708 M Cost of revenue 19 B19.8 B19.1 B17.34 B19.27 B 75.51 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 287 M291 M296 M307 M293 M 1.19 B